Dr Oded Breuer, a physician/clinician at Hadassah Hospital, will complete his two-year paediatric respiratory fellowship at the Princess Margaret Hospital for Children (PMHC) in Perth in April, 2019. PMHC is a world leader in the treatment and management of Cystic Fibrosis (CF).

CF is a genetic disorder that primarily affects the lungs and digestive system because of a malfunction in the exocrine system that’s responsible for producing saliva, sweat, tears and mucus. There is currently no cure. With nine months left of his stay in Australia, Hadassah Australia is looking to raise the final $18,000 needed to complete the $240,000 fellowship, which has been jointly funded by Hadassah Australia and AUSiMED.

Professor Stephen Stick, Head of the Department of Respiratory Medicine at Princess Margaret Hospital, paid tribute to Hadassah Hospital. He considers it has one of the leading cystic fibrosis centres in the world. He said,

“Its work is having an ongoing impact on research for new therapies for patients with cystic fibrosis.”

The purpose of the research and clinical fellowship is for Dr Breuer to learn from the unique clinical approach at PMHC in treatment and follow-up of early CF lung disease. This will enable him to establish an up-to-date early management strategy for infants and children with CF in Israel. And to work with Professor Eitan Kerem, Head of Paediatrics at Hadassah and an internationally-recognised expert on CF. It will also allow Dr Breuer to develop a lasting clinical and research collaboration between the Department of Paediatric Medicine at PMHC and Hadassah in Jerusalem.

He also acknowledged the outstanding work of Dr Breuer, Oded Breuer’s interest in rare diseases and connections with geneticists in Jerusalem has significantly contributed to our practice in Perth, and has provided opportunities to better diagnose and treat children with orphan lung diseases. He has proved to be an exceptionally curious and diligent young physician.